Related Experiment Video
Updated: May 16, 2025

11:34
Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
Published on: August 9, 2019
6.6K
Single-step discovery of high-affinity RNA ligands by UltraSelex
Yaqing Zhang1,2, Yuan Jiang3, David Kuster4
1Institute of Pharmacy and Molecular Biotechnology (IPMB), Heidelberg University, Heidelberg, Germany. yaqing.zhang@uni-heidelberg.de.
Nature Chemical Biology
|March 31, 2025
Summary
UltraSelex rapidly discovers RNA aptamers in about one day, overcoming limitations of traditional methods. This new technique enables applications in live-cell imaging and enzyme inhibition, accelerating drug discovery.
Area of Science:
- Biochemistry
- Molecular Biology
- Biotechnology
Background:
- Aptamers are nucleic acid ligands with diverse applications, including therapeutics and diagnostics.
- Traditional aptamer discovery (SELEX) is laborious, time-consuming, and may yield suboptimal candidates.
- There is a need for faster, more efficient aptamer discovery methods.
Purpose of the Study:
- To develop a rapid, noniterative method for discovering high-affinity RNA aptamers.
- To demonstrate the utility of the new method for identifying aptamers against diverse targets.
- To enable rapid inference of minimal aptamer motifs.
Main Methods:
- UltraSelex combines biochemical partitioning, high-throughput sequencing, and computational rank modeling.
- This noniterative approach streamlines the aptamer selection process.
- The method achieves aptamer discovery in approximately one day.
Main Results:
- UltraSelex successfully identified high-affinity RNA aptamers targeting a silicon rhodamine dye and two proteins.
- Identified aptamers enabled live-cell RNA imaging and efficient inhibition of SARS-CoV-2 RNA-dependent RNA polymerase and HIV reverse transcriptase.
- Minimal aptamer motifs were readily inferred from the ranked sequences.
Conclusions:
- UltraSelex offers a significantly faster alternative to conventional aptamer discovery.
- The method accelerates the identification of novel aptamers for drug candidates and diagnostic tools.
- UltraSelex facilitates rapid development of aptamer-based technologies.

